Tumor angiogenic activity of gynecologic tumor cell lines on the chorioallantoic membrane. 1988

I Ishiwata, and C Ishiwata, and M Soma, and I Ono, and T Nakaguchi, and H Ishikawa
Ishiwata Obstetrics and Gynecologic Hospital, Ibaraki-ken, Japan.

Tumor angiogenic activity (TAA) from tumor angiogenesis factor (TAF), produced by 24 cell lines of various kinds of gynecologic tumors, was assayed onto chorioallantoic membranes (CAMs) of chick embryos. Methylcellulose (1%) pellets containing 1 x 10(7) cells were placed on 8-day-old postfertilized CAMs, and the grade of neovascularization was assayed 3 days after inoculation. Neovascularization occurred prominently in such cell lines, as HTBOA (poorly differentiated ovarian carcinoma), HUOCA-II (poorly differentiated clear cell adenocarcinoma), HWUA (poorly differentiated endometrial adenocarcinoma), and in HKUS (uterine cervical small cell carcinoma); however, neovascularization did not occur in SNK (uterine leiomyosarcoma line). The cell lines which secreted TAF showed high heterotransplantability in the nude mice and produced rapidly growing tumors which were rich in blood vessels. However, the SKN line which did not secret TAF was not transplantable. These results suggested that there was a close relationship among TAA, transplantability, and tumor growth rate.

UI MeSH Term Description Entries
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick
D002823 Chorion The outermost extra-embryonic membrane surrounding the developing embryo. In REPTILES and BIRDS, it adheres to the shell and allows exchange of gases between the egg and its environment. In MAMMALS, the chorion evolves into the fetal contribution of the PLACENTA. Chorions
D005260 Female Females
D005833 Genital Neoplasms, Female Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE). Gynecologic Neoplasms,Female Genital Neoplasms,Neoplasms, Female Genital,Neoplasms, Gynecologic,Female Genital Neoplasm,Genital Neoplasm, Female,Gynecologic Neoplasm,Neoplasm, Female Genital,Neoplasm, Gynecologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000482 Allantois An extra-embryonic membranous sac derived from the YOLK SAC of REPTILES; BIRDS; and MAMMALS. It lies between two other extra-embryonic membranes, the AMNION and the CHORION. The allantois serves to store urinary wastes and mediate exchange of gas and nutrients for the developing embryo. Allantoic Membrane,Membrane, Allantoic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014183 Transplantation, Heterologous Transplantation between animals of different species. Xenotransplantation,Heterograft Transplantation,Heterografting,Heterologous Transplantation,Xenograft Transplantation,Xenografting,Transplantation, Heterograft,Transplantation, Xenograft

Related Publications

I Ishiwata, and C Ishiwata, and M Soma, and I Ono, and T Nakaguchi, and H Ishikawa
January 1982, Zhurnal obshchei biologii,
I Ishiwata, and C Ishiwata, and M Soma, and I Ono, and T Nakaguchi, and H Ishikawa
April 2012, Vascular cell,
I Ishiwata, and C Ishiwata, and M Soma, and I Ono, and T Nakaguchi, and H Ishikawa
September 1985, Laboratory investigation; a journal of technical methods and pathology,
I Ishiwata, and C Ishiwata, and M Soma, and I Ono, and T Nakaguchi, and H Ishikawa
January 2001, Methods in molecular medicine,
I Ishiwata, and C Ishiwata, and M Soma, and I Ono, and T Nakaguchi, and H Ishikawa
January 1988, Experimental pathology,
I Ishiwata, and C Ishiwata, and M Soma, and I Ono, and T Nakaguchi, and H Ishikawa
June 2021, Pharmaceutics,
I Ishiwata, and C Ishiwata, and M Soma, and I Ono, and T Nakaguchi, and H Ishikawa
April 1983, Cancer research,
I Ishiwata, and C Ishiwata, and M Soma, and I Ono, and T Nakaguchi, and H Ishikawa
December 1985, Biochemistry,
I Ishiwata, and C Ishiwata, and M Soma, and I Ono, and T Nakaguchi, and H Ishikawa
March 1977, Indian journal of experimental biology,
I Ishiwata, and C Ishiwata, and M Soma, and I Ono, and T Nakaguchi, and H Ishikawa
March 2006, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!